Frequency and clinical significance of a variety of autoantibodies in patients with definite infective endocarditis

Journal of Clinical Rheumatology

Volumn 18, Issue 2, 2012, Pages 67-70

  Bojalil, Rafael ^a   Mazón González, Betania ^a   Carrillo Córdova, Jorge R ^a   Springall, Rashidi ^a   Amezcua Guerra, Luis M ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Anti CCP; Autoantibody; Infective endocarditis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LA ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG EDEMA; LUNG EMBOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STROKE;

ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC ERRORS; ENDOCARDITIS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PULMONARY EMBOLISM;

EID: 84859757839     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318247caf0     Document Type: Article

References (14)

1. González-Juanatey C, González-Gay MA, Llorca J, et al. Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study. Medicine (Baltimore). 2001;80:9Y19. (Pubitemid 32066375)
2. Kupferwasser LI, Hafner G, Mohr-Kahaly S, et al. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol. 1999;33:1365Y1371.
3. Tiliakos AM, Tiliakos NA. Dual ANCA positivity in subacute bacterial endocarditis. J Clin Rheumatol. 2008;14:38Y40.
4. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633Y638.
5. Whiting PF, Smidt N, Sterne JA, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med. 2010;152:456Y464.
6. Antico A, Platzgummer S, Bassetti D, et al. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus. 2010;19:906Y912.
7. Mahler M, Waka A, Hiepe F, et al. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus. Arthritis Res Ther. 2007;9:R68.
8. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5:80Y93. (Pubitemid 36849754)
9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295Y306.
10. Makrygiannakis D, af Klint E, Lundberg IE, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis. 2006;65:1219Y1222. (Pubitemid 44277400)
11. Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against cyclic citrullinated peptides in patients with "rhupus": a cross-sectional study. Arthritis Res Ther. 2006;8:R144.
12. Lima I, Santiago M. Antibodies against cyclic citrullinated peptides in infectious diseasesVa systematic review. Clin Rheumatol. 2010;29:1345Y1351.
13. Kakumanu P, Yamagata H, Sobel ES, et al. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum. 2008;58:1576Y1581. (Pubitemid 351847510)
14. Murdoch DR, Corey R, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. The International Collaboration on EndocarditisVProspective Cohort Study. Arch Intern Med. 2009;169:463Y473.